Abstract: Provided are a method and apparatus for providing a counseling service. A method of operating a counseling center server interworking with an instant messaging service includes activating a connection with a chatbot server linked to a channel in a chat room, calling a chatbot block corresponding to a specific task included in the chatbot server through the chat room, transmitting a message received from a terminal of a user connected to the chat room to the chatbot server as an input of the chatbot block, and transmitting an output of the chatbot block in response to the message received from the chatbot server to the terminal of the user.

Abstract: A method includes: forming a MOSFET layer on a semiconductor wafer substrate, the MOSFET layer including: pixel driver circuits; and a display driver circuit; forming at least one line layer on the MOSFET layer; applying a first supply voltage to a first supply voltage line through a first supply voltage pad; connecting data fan-out lines connected to the pixel driver circuits with a first test line by controlling a test switching circuit in the MOSFET layer; measuring an electrical signal generated from each of the pixel driver circuits through a first test pad connected to the first test line; determining whether each of the pixel driver circuits is defective or not based on the measured electrical signal; and forming a light-emitting element layer including light-emitting elements on the at least one line layer when that the pixel driver circuits are determined to be not defective.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: A refrigerant charging system includes: a reliquefaction system reliquefying boil-off gas generated in a liquefied gas storage tank by compressing the boil-off gas and subjecting the compressed boil-off gas to heat exchange with refrigerant supplied to a heat exchanger while circulating along a refrigerant circulation line; a buffer tank storing utility N2 to be supplied to the ship; a booster compressor receiving the utility N2 from the buffer tank, compressing the received N2, and supplying the compressed N2 to the refrigerant circulation line; and a first load-up line along which the N2 is supplied from the buffer tank to the refrigerant circulation line without passing through the booster compressor. Upon initial charging in a non-operation state of the reliquefaction system, the refrigerant circulation line is charged with refrigerant by supplying the N2 from by a pressure differential between the refrigerant circulation line and the buffer tank.

Abstract: An apparatus may provide a controller, and a memory configured to store at least one instruction. The at least one instruction when executed by the controller, may cause the apparatus to receive, from a user device, a request for storage information, the request including at least one of storage company information, branch information, or space information for each branch; transmit, to the user device and based on the request, the storage information, receive, from the user device, an experience request for at least a storage of a plurality of storages associated with the storage information, and transmit, to the user device and based on the experience request, experience information for the storage, wherein the experience information may include a three dimensional simulation result associated with the storage.

Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Abstract: The present invention can provide light-colored magnetic particles having a zirconium oxide coating layer formed on a magnetic core, and having a silver coating layer formed on the zirconium oxide coating layer, and a part of the surface of the zirconium oxide coating layer is exposed to the outside, but chemical resistance is excellent, and thus the magnetic particles hardly cause a change of magnetic characteristics so as to be suitable for security elements.

Abstract: The present invention relates to a security device comprising a colloidal crystal which exhibits excellent visibility and is also easily manufactured. The security device, according to the present invention, comprises: a substrate; a groove part formed on the substrate; a colloidal crystal positioned in the groove part; and an aging film. The security device, according to the present invention, exhibits excellent security and visibility, and thus may be used for securities, credit cards, security cards, anti-forgery products, etc.

Abstract: The present invention relates to a security device comprising a colloidal crystal which exhibits excellent visibility and is also easily manufactured. The security device, according to the present invention, comprises: a substrate; a groove part formed on the substrate; a colloidal crystal positioned in the groove part; and an aging film. The security device, according to the present invention, exhibits excellent security and visibility, and thus may be used for securities, credit cards, security cards, anti-forgery products, etc.

Abstract: The present invention can provide light-colored magnetic particles having a zirconium oxide coating layer formed on a magnetic core, and having a silver coating layer formed on the zirconium oxide coating layer, and a part of the surface of the zirconium oxide coating layer is exposed to the outside, but chemical resistance is excellent, and thus the magnetic particles hardly cause a change of magnetic characteristics so as to be suitable for security elements.